ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

D467 Thames Ventures Vct 2 Plc

14.00
0.00 (0.00%)
Last Updated: 08:00:01
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Thames Ventures Vct 2 Plc LSE:D467 London Ordinary Share GB00BWX53D91 DP67 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 14.00 9.00 19.00 14.00 13.50 14.00 25,000 08:00:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice -6.02M -7.66M -0.0777 -12.81 98.05M

Downing FOUR VCT plc Portfolio Update And Net Asset Value

23/07/2021 9:16am

UK Regulatory


Thames Ventures Vct 2 (LSE:D467)
Historical Stock Chart


From Apr 2021 to Apr 2024

Click Here for more Thames Ventures Vct 2 Charts.
 
TIDMD467 
 

Downing FOUR VCT plc (the "Company")

LEI: 21380035MV1VRYEXPR95

23 July 2021

Portfolio Update and Net Asset Value

The Directors of the Company are pleased to report that GENinCode plc ("GENinCode"), a portfolio company of the Healthcare Share class, had its ordinary shares admitted to trading on AIM on 22 July and also raised GBP17.0 million through the placing of and subscription for, new ordinary shares, taking the market capitalisation of GENinCode to approximately GBP42.2 million on admission. The placing price was 44.0p per GENinCode ordinary share.

Based on the placing price, the increase in the value of the GENinCode holding in the Company's Healthcare Share has resulted in an increase in the Healthcare Share class NAV of approximately 8.2p per Healthcare Share. The Company previously announced, on 6 July, that the unaudited NAV per Healthcare Share as at 30 June 2021 was 73.8p. Adjusting for this uplift gives an unaudited NAV of 82.0p per Healthcare Share.

Enquiries:

Grant Whitehouse

Downing LLP

Company Secretary

020 7630 4333

 
 

(END) Dow Jones Newswires

July 23, 2021 04:16 ET (08:16 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Thames Ventures Vct 2 Chart

1 Year Thames Ventures Vct 2 Chart

1 Month Thames Ventures Vct 2 Chart

1 Month Thames Ventures Vct 2 Chart

Your Recent History

Delayed Upgrade Clock